Reshma Abdulla Rangwala

Title: Reshma Abdulla Rangwala: Innovator in Cancer Treatment

Introduction

Reshma Abdulla Rangwala is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 3 patents, her work focuses on combining various antibodies to enhance cancer therapies.

Latest Patents

One of her latest patents involves methods of treating cancer with a combination of an anti-VEGF antibody and an anti-tissue factor antibody-drug conjugate. This invention provides an anti-VEGF antibody, such as bevacizumab, in combination with an antibody-drug conjugate that binds to tissue factor (TF), like tisotumab vedotin. This combination is particularly useful in treating cancers, including cervical cancer. Additionally, she has developed methods of treating cancer using an anti-PD-1 antibody combined with an anti-tissue factor antibody-drug conjugate. This invention includes an anti-PD-1 antibody comprising the complementary determining regions (CDRs) of pembrolizumab, paired with an antibody-drug conjugate that binds to TF, which is effective in treating breast and cervical cancers.

Career Highlights

Throughout her career, Reshma has worked with notable companies such as Genmab and MSD International GmbH. Her experience in these organizations has contributed to her expertise in developing innovative cancer treatments.

Collaborations

Some of her coworkers include Esther C. W. Breij and Sandra Verploegen, who have collaborated with her on various projects related to cancer research.

Conclusion

Reshma Abdulla Rangwala's contributions to cancer treatment through her patented inventions highlight her role as a leading innovator in the field. Her work continues to pave the way for advancements in cancer therapies.